BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35816617)

  • 1. Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer.
    Wang Q; Stone K; Kern JA; Slatore CG; Swanson S; Blackstock W; Khan RS; Smith CB; Veluswamy RR; Chidel M; Wisnivesky JP
    Ann Am Thorac Soc; 2022 Dec; 19(12):2053-2061. PubMed ID: 35816617
    [No Abstract]   [Full Text] [Related]  

  • 2. Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection.
    Sullivan DR; Wisnivesky JP; Nugent SM; Stone K; Farris MK; Kern JA; Swanson S; Smith CB; Rosenzweig K; Slatore CG
    Clin Oncol (R Coll Radiol); 2023 Jun; 35(6):e352-e361. PubMed ID: 37031075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.
    Ezer N; Veluswamy RR; Mhango G; Rosenzweig KE; Powell CA; Wisnivesky JP
    J Thorac Oncol; 2015 Aug; 10(8):1201-6. PubMed ID: 26200275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer.
    Kishi N; Matsuo Y; Menju T; Hamaji M; Nakakura A; Hanazawa H; Takehana K; Date H; Mizowaki T
    J Radiat Res; 2022 Sep; 63(5):758-771. PubMed ID: 35818291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
    Mayne NR; Lin BK; Darling AJ; Raman V; Patel DC; Liou DZ; D'Amico TA; Yang CJ
    Ann Surg; 2020 Dec; 272(6):925-929. PubMed ID: 33074904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer.
    Singh AK; Hennon M; Ma SJ; Demmy TL; Picone A; Dexter EU; Nwogu C; Attwood K; Tan W; Hermann GM; Fung-Kee-Fung S; Malhotra HK; Yendamuri S; Gomez-Suescun JA
    BMC Cancer; 2018 Nov; 18(1):1183. PubMed ID: 30497431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.
    Yu JB; Soulos PR; Cramer LD; Decker RH; Kim AW; Gross CP
    Cancer; 2015 Jul; 121(14):2341-9. PubMed ID: 25847699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
    Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
    Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study.
    Claude L; Morelle M; Mahé MA; Pasquier D; Boisselier P; Bondiau PY; Touboul E; Peignaux-Casasnovas K; Martel-Lafay I; Gassa F; Perrier L; Dussart S; Beckendorf V
    Br J Radiol; 2020 Dec; 93(1116):20200256. PubMed ID: 32970478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer.
    Wolff HB; Alberts L; Kastelijn EA; Lissenberg-Witte BI; Twisk JW; Lagerwaard FJ; Senan S; El Sharouni SY; Schramel FMNH; Coupé VMH
    J Thorac Oncol; 2018 May; 13(5):689-698. PubMed ID: 29391288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.
    de Ruiter JC; Heineman DJ; Daniels JM; van Diessen JN; Damhuis RA; Hartemink KJ
    Lung Cancer; 2020 Jun; 144():64-70. PubMed ID: 32371262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Dependency in Older Adults After Surgery or Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Hirpara DH; Kidane B; Louie AV; Zuk V; Darling G; Rousseau M; Chesney T; Coburn N; Hallet J;
    Ann Surg; 2023 Aug; 278(2):e368-e376. PubMed ID: 35968895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ
    Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
    Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
    Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.